AKT1 and cancer: From the results of functional enrichment, we noticed significant converged pathways among three groups (PT1 vs. RT1.1st, PT1 vs. RT1.2nd, and PT2 vs. RT2) including metabolic pathways, pathway in cancer, neuroactive ligand–receptor interaction, and PI3K-AKT signaling pathways (Figure 2D).